Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical gene therapy for nonmalignant disease.

Thomas A Ratko1, Joseph P Cummings, John Blebea

  • 1Clinical Knowledge Services, University HealthSystem Consortium, Oak Brook, Illinois 60523-1890, USA. ratko@uhc.edu

The American Journal of Medicine
|November 6, 2003
PubMed
Summary

Gene therapy shows limited evidence of benefit for genetic disorders like cystic fibrosis and hemophilia. Further research is crucial as no Phase 3 trials confirm clinical efficacy for gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

General and disease-specific quality-of-life improvement following superficial venous insufficiency treatment.

Journal of vascular surgery. Venous and lymphatic disorders·2025
Same author

Percutaneous Transluminal Venous Angioplasty for Neurogenic Thoracic Outlet Syndrome.

Annals of vascular surgery·2025
Same author

Clinical outcomes following treatment for small saphenous vein insufficiency: An AVLS PRO venous registry study.

Phlebology·2025
Same author

Ultrasound-guided foam sclerotherapy using physician-compounded foam: Position statement from the American vein and lymphatic society.

Phlebology·2024
Same author

Protocol-based treatment of spontaneous hemorrhage from varicose veins prevents recurrence of bleeding.

Journal of vascular surgery. Venous and lymphatic disorders·2024
Same author

Mechanochemical chemically assisted ablation of varicose veins for venous insufficiency: American vein and lymphatic society position statement.

Phlebology·2024

Area of Science:

  • Biotechnology
  • Medical Genetics
  • Clinical Research

Background:

  • Gene therapy offers potential definitive treatment for genetic diseases.
  • Current gene therapy approaches aim for targeted genetic material transfer and expression.

Purpose of the Study:

  • To review clinical gene therapy trials for various disorders.
  • To assess the current evidence for gene therapy's clinical benefits.

Main Methods:

  • Systematic review of clinical gene therapy trials.
  • Analysis of trials for nonmalignant, single-gene, multifactorial, and infectious diseases.

Main Results:

  • Limited evidence suggests potential benefits for severe combined immunodeficiency, cystic fibrosis, coronary/peripheral arterial disease, and hemophilia.

Related Experiment Videos

  • No Phase 3 randomized controlled trials have been completed to confirm efficacy.
  • Difficulty in correlating clinical benefits with gene therapy administration.

    • Conclusions:

    • Additional clinical and basic research is necessary.
    • The future role of gene therapy requires further investigation to establish definitive clinical benefits.